Am J Physiol Cell Physiol Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 294: C345-C354, 2008. First published October 17, 2007; doi:10.1152/ajpcell.00216.2007
0363-6143/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/C345    most recent
00216.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Black, S. M.
Right arrow Articles by Wedgwood, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, S. M.
Right arrow Articles by Wedgwood, S.

RECEPTORS AND SIGNAL TRANSDUCTION

Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation

Stephen M. Black,1 Jennifer M. DeVol,2 and Stephen Wedgwood2

1Vascular Biology Center, Medical College of Georgia, Augusta, Georgia; and 2Department of Pediatrics, Division of Neonatology, Northwestern University, Chicago, Illinois

Submitted 24 May 2007 ; accepted in final form 11 October 2007

We have previously demonstrated increased fibroblast growth factor-2 (FGF-2) expression in a lamb model of increased pulmonary blood flow secondary to congenital heart disease, which may contribute to the associated increases in pulmonary arterial muscularization. However, the mechanisms underlying these increases in FGF-2 expression remain to be identified. Initially, we found that exogenous FGF-2 increased endogenous FGF-2 promoter activity and protein levels in ovine pulmonary arterial smooth muscle cells (PASMC). Furthermore, we found that these increases in FGF-2 expression were mediated by increases in superoxide levels via NADPH oxidase activation. In addition, FGF-2-mediated increases in FGF-2 expression and PASMC proliferation were attenuated by inhibition of phosphatidylinositol 3-kinase, Akt, and NADPH oxidase. Increases in FGF-2 expression could be stimulated by other factors known to increase reactive oxygen species (ROS) signaling in PASMC (endothelin-1 and transforming growth factor-β1), whereas antioxidants attenuated these increases. Deletion constructs localized the growth factor- and ROS-sensitive region within the proximal 103 bp of the FGF-2 promoter, and sequence analysis identified a putative hypoxia response element (HRE), a DNA binding site for the ROS-sensitive transcription factor hypoxia-inducible factor-1{alpha} (HIF-1{alpha}). Stabilization of HIF-1{alpha} increased FGF-2 promoter activity, whereas mutation of the putative HRE attenuated FGF-2-induced FGF-2 promoter activity. Furthermore, FGF-2 increased HIF-1{alpha} protein levels and consensus HRE promoter activity in PASMC via antioxidant-sensitive mechanisms. Thus we conclude that FGF-2 can stimulate its own expression in PASMC via NADPH oxidase-mediated activation of ROS-sensitive transcription factors, including HIF-1{alpha}. This positive feedback mechanism may contribute to pulmonary vascular remodeling associated with increased pulmonary blood flow.

cell signaling; proliferation; pulmonary hypertension



Address for reprint requests and other correspondence: S. Wedgwood, Dept. of Pediatrics, Division of Neonatology, Northwestern Univ., Ward 12-189, 303 E. Chicago Ave., Chicago, IL 60611 (e-mail: s-wedgwood{at}northwestern.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
H. Sauer and M. Wartenberg
Circulating Isoprostanes: Gate Keepers in the Route From Oxidative Stress to Vascular Dysfunction
Circ. Res., October 24, 2008; 103(9): 907 - 909.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.